{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:24:34Z","timestamp":1787181874395,"version":"build-2736575974"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Gobierno de Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007747","name":"Spanish Multiple Sclerosis Network","doi-asserted-by":"publisher","award":["RED2024-153909-E"],"award-info":[{"award-number":["RED2024-153909-E"]}],"id":[{"id":"10.13039\/501100007747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI23\/00749"],"award-info":[{"award-number":["PI23\/00749"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI20\/01634"],"award-info":[{"award-number":["PI20\/01634"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Community of Madrid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.biopha.2026.119836","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T14:32:19Z","timestamp":1786199539000},"page":"119836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mitochondrial bioenergetic remodeling underlies fingolimod-induced immunometabolic adaptation in multiple sclerosis"],"prefix":"10.1016","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2997-8569","authenticated-orcid":false,"given":"Adela","family":"Gonz\u00e1lez-Jim\u00e9nez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1578-0110","authenticated-orcid":false,"given":"Pilar","family":"L\u00f3pez-Cotarelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5881-3393","authenticated-orcid":false,"given":"Alba","family":"Moreno-Jerez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8805-7320","authenticated-orcid":false,"given":"Jordina","family":"Vela-Artiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6536-4160","authenticated-orcid":false,"given":"Estela","family":"Mena-Plaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9459-5452","authenticated-orcid":false,"given":"Yolanda","family":"Aladro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0084-2254","authenticated-orcid":false,"given":"Bel\u00e9n","family":"Pilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9221-5716","authenticated-orcid":false,"given":"Celia","family":"Oreja-Guevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7743-3953","authenticated-orcid":false,"given":"Irene","family":"G\u00f3mez-Est\u00e9vez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0054-3828","authenticated-orcid":false,"given":"Andrea R.","family":"L\u00f3pez-Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9734-8788","authenticated-orcid":false,"given":"Irene","family":"G\u00f3mez-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8470-8396","authenticated-orcid":false,"given":"Elena","family":"Urcelay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5566","key":"10.1016\/j.biopha.2026.119836_bib1","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.1070238","article-title":"Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists","volume":"296","author":"Mandala","year":"2002","journal-title":"Science"},{"issue":"8 3","key":"10.1016\/j.biopha.2026.119836_bib2","article-title":"Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis","volume":"76","author":"Mehling","year":"2011","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.biopha.2026.119836_bib3","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nrd3248","article-title":"Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis","volume":"9","author":"Brinkmann","year":"2010","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"2","key":"10.1016\/j.biopha.2026.119836_bib4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple Sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119836_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2025.101947","article-title":"The role of the adaptive immune system in the initiation and persistence of multiple sclerosis","volume":"78","author":"Afzali","year":"2025","journal-title":"Semin. Immunol."},{"issue":"808","key":"10.1016\/j.biopha.2026.119836_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adp8109","article-title":"Tissue-resident memory CD4+ T cells infiltrate the CNS in progressive multiple sclerosis and contribute to chronic autoimmunity in mice","volume":"17","author":"Pignata","year":"2025","journal-title":"Sci. Transl. Med."},{"issue":"8083","key":"10.1016\/j.biopha.2026.119836_bib7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41586-025-09378-0","article-title":"EBV induces CNS homing of B cells attracting inflammatory T cells","volume":"646","author":"L\u00e4derach","year":"2025","journal-title":"Nature"},{"issue":"117","key":"10.1016\/j.biopha.2026.119836_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aec1627","article-title":"Intestinal epithelial MHC class II induces encephalitogenic CD4 T cells and initiates central nervous system autoimmunity","volume":"11","author":"Suzuki","year":"2026","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.biopha.2026.119836_bib9","article-title":"Mitochondrial transplantation ameliorates experimental autoimmune encephalomyelitis by modulating the Th17\/Treg balance and restoring metabolic homeostasis","volume":"17","author":"Lee","year":"2026","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119836_bib10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41582-023-00839-6","article-title":"Implications of immunometabolism for smouldering MS pathology and therapy","volume":"19","author":"Bittner","year":"2023","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119836_bib11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nm1564","article-title":"Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation","volume":"13","author":"Korn","year":"2007","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.biopha.2026.119836_bib12","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","article-title":"Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets","volume":"186","author":"Michalek","year":"2011","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119836_bib13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/cen3.12591","article-title":"Regulatory T cells in multiple sclerosis","volume":"11","author":"Kimura","year":"2020","journal-title":"Clin. Exp. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119836_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-024-03016-8","article-title":"Mitochondrial and metabolic dysfunction of peripheral immune cells in multiple sclerosis","volume":"21","author":"Wang","year":"2024","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2026.119836_bib15","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.immuni.2016.01.028","article-title":"The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements","volume":"44","author":"Procaccini","year":"2016","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.biopha.2026.119836_bib16","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41583-024-00823-z","article-title":"The neuropathobiology of multiple sclerosis","volume":"25","author":"Woo","year":"2024","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2026.119836_bib17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12031-008-9115-1","article-title":"Variations in mitochondrial DNA copy numbers in MS brains","volume":"35","author":"Blokhin","year":"2008","journal-title":"J. Mol. Neurosci."},{"issue":"7","key":"10.1016\/j.biopha.2026.119836_bib18","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/1873-3468.13013","article-title":"Mitochondrial dysfunction and axon degeneration in progressive multiple sclerosis","volume":"592","author":"Campbell","year":"2018","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2026.119836_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.05.012","article-title":"Targeting mitochondria to protect axons in progressive MS","volume":"710","author":"Campbell","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2026.119836_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.61798","article-title":"Enhancing mitochondrial activity in neurons protects against neurodegeneration in a mouse model of multiple sclerosis","volume":"10","author":"Rosenkranz","year":"2021","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.biopha.2026.119836_bib21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.molmed.2013.11.007","article-title":"Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis","volume":"20","author":"Witte","year":"2014","journal-title":"Trends Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2026.119836_bib22","article-title":"Mitochondrial Dysfunction and Multiple Sclerosis","volume":"8","author":"de Barcelos","year":"2019","journal-title":"Biol. (Basel)"},{"issue":"11","key":"10.1016\/j.biopha.2026.119836_bib23","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","article-title":"Progressive multiple sclerosis: pathology and pathogenesis","volume":"8","author":"Lassmann","year":"2012","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119836_bib24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/imm.12272","article-title":"Sphingosine-1-phosphate receptor 1 signalling in T cells: trafficking and beyond","volume":"142","author":"Garris","year":"2014","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.biopha.2026.119836_bib25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119836_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26073351","article-title":"Mitochondrial Changes Induced by SGLT2i in Lymphocytes from Diabetic Kidney Transplant Recipients: A Pilot Study","volume":"26","author":"P\u00e9rez-Flores","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119836_bib27","doi-asserted-by":"crossref","DOI":"10.1007\/s10565-024-09976-0","article-title":"Long-term mitochondrial and metabolic impairment in lymphocytes of subjects who recovered after severe COVID-19","volume":"41","author":"G\u00f3mez-Delgado","year":"2025","journal-title":"Cell. Biol. Toxicol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119836_bib28","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1073\/pnas.96.6.3047","article-title":"An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect","volume":"96","author":"Chesney","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.biopha.2026.119836_bib29","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2174\/156652412803833599","article-title":"Molecular targets of FTY720 (fingolimod)","volume":"12","author":"Pitman","year":"2012","journal-title":"Curr. Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2026.119836_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1124\/pr.107.07113","article-title":"Inside-out\u201d signaling of sphingosine-1-phosphate: therapeutic targets","volume":"60","author":"Takabe","year":"2008","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2026.119836_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cells9051290","article-title":"Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis","volume":"9","author":"Musella","year":"2020","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.biopha.2026.119836_bib32","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00011-012-0454-6","article-title":"FTY720 mediates activation suppression and G(0)\/G (1) cell cycle arrest in a concanavalin A-induced mouse lymphocyte pan-activation model","volume":"61","author":"Zeng","year":"2012","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.biopha.2026.119836_bib33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clim.2016.11.008","article-title":"The sphingosine-1-phosphate receptor: A novel therapeutic target for multiple sclerosis and other autoimmune diseases","volume":"175","author":"Mao-Draayer","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.biopha.2026.119836_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00493","article-title":"Metabolic Reprograming of Microglia in the Regulation of the Innate Inflammatory Response","volume":"11","author":"Lauro","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119836_bib35","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.45114","article-title":"Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS","volume":"8","author":"Manzo","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.biopha.2026.119836_bib36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jbiotec.2015.02.015","article-title":"Bioenergetics profile of CD4+ T cells in relapsing remitting multiple sclerosis subjects","volume":"202","author":"De Riccardis","year":"2015","journal-title":"J. Biotechnol."},{"issue":"7851","key":"10.1016\/j.biopha.2026.119836_bib37","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","article-title":"Metabolic support of tumour-infiltrating regulatory T cells by lactic acid","volume":"591","author":"Watson","year":"2021","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.biopha.2026.119836_bib38","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175897","article-title":"Lactate supports Treg function and immune balance via MGAT1 effects on N-glycosylation in the mitochondria","volume":"134","author":"Zhou","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"6155","key":"10.1016\/j.biopha.2026.119836_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/science.1242454","article-title":"Fueling immunity: insights into metabolism and lymphocyte function","volume":"342","author":"Pearce","year":"2013","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.biopha.2026.119836_bib40","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrd4626","article-title":"SLC transporters as therapeutic targets: emerging opportunities","volume":"14","author":"Lin","year":"2015","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"6","key":"10.1016\/j.biopha.2026.119836_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104435","article-title":"Monocarboxylate transporter 1 deficiency impacts CD8+ T lymphocytes proliferation and recruitment to adipose tissue during obesity","volume":"25","author":"Macchi","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.biopha.2026.119836_bib42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaut.2018.08.002","article-title":"Fingolimod modulates T cell phenotype and regulatory T cell plasticity in vivo","volume":"96","author":"Dominguez-Villar","year":"2019","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.biopha.2026.119836_bib43","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cmet.2019.11.021","article-title":"Mitochondrial Integrity Regulated by Lipid Metabolism Is a Cell-Intrinsic Checkpoint for Treg Suppressive Function","volume":"31","author":"Field","year":"2020","journal-title":"Cell. Metab."},{"key":"10.1016\/j.biopha.2026.119836_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.703972","article-title":"Targeting Mitochondrial-Derived Reactive Oxygen Species in T Cell-Mediated Autoimmune Diseases","volume":"12","author":"Ch\u00e1vez","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119836_bib45","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/jnc.15169","article-title":"Metabolic determinants of leukocyte pathogenicity in neurological diseases","volume":"158","author":"Runtsch","year":"2021","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.biopha.2026.119836_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2026.103989","article-title":"Metabolic traits of T cells and the implications in autoimmune diseases","volume":"25","author":"Zhou","year":"2026","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2026.119836_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13376-2","article-title":"S1P1 deletion differentially affects TH17 and Regulatory T cells","volume":"7","author":"Eken","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119836_bib48","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cell.2013.08.032","article-title":"Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency","volume":"155","author":"Cogliati","year":"2013","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.biopha.2026.119836_bib49","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.chembiol.2023.08.008","article-title":"Metabolic modulation of mitochondrial mass during CD4+ T cell activation","volume":"30","author":"Kurmi","year":"2023","journal-title":"Cell. Chem. Biol."},{"issue":"6098","key":"10.1016\/j.biopha.2026.119836_bib50","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1126\/science.1219855","article-title":"Mitochondrial fission, fusion, and stress","volume":"337","author":"Youle","year":"2012","journal-title":"Science"},{"issue":"7932","key":"10.1016\/j.biopha.2026.119836_bib51","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-022-05264-1","article-title":"An LKB1-mitochondria axis controls TH17 effector function","volume":"610","author":"Baixauli","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2026.119836_bib52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/imm.13870","article-title":"Sphingosine-1-Phosphate Signalling Inhibition Suppresses Th1-Like Treg Generation by Reversing Mitochondrial Uncoupling","volume":"174","author":"Coulombeau","year":"2025","journal-title":"Immunology"},{"issue":"8","key":"10.1016\/j.biopha.2026.119836_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/cells8080795","article-title":"Mitochondrial Uncoupling: A Key Controller of Biological Processes in Physiology and Diseases","volume":"8","author":"Demine","year":"2019","journal-title":"Cells"},{"issue":"7740","key":"10.1016\/j.biopha.2026.119836_bib54","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41586-018-0846-z","article-title":"Mitochondrial complex III is essential for suppressive function of regulatory T cells","volume":"565","author":"Weinberg","year":"2019","journal-title":"Nature"},{"issue":"490","key":"10.1016\/j.biopha.2026.119836_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao5563","article-title":"Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects","volume":"11","author":"Klotz","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.biopha.2026.119836_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202451260","article-title":"Teriflunomide Inhibits Human FOXP3+ Regulatory T Cell Function by Interference With Mitochondrial Respiration","volume":"55","author":"Dyczko","year":"2025","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2026.119836_bib57","article-title":"Mitochondrial reverse electron transport in myeloid cells perpetuates neuroinflammation","author":"Peruzzotti-Jametti","year":"2024","journal-title":"bioRxiv Prepr. Serv. Biol. Publ. Online Jan. 4"},{"issue":"1","key":"10.1016\/j.biopha.2026.119836_bib58","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2016.05.035","article-title":"Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming","volume":"166","author":"Buck","year":"2016","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.biopha.2026.119836_bib59","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1016\/j.cell.2025.05.029","article-title":"The immunoproteasome disturbs neuronal metabolism and drives neurodegeneration in multiple sclerosis","volume":"188","author":"Woo","year":"2025","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.biopha.2026.119836_bib60","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/ncb1881","article-title":"The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC\/C-Cdh1","volume":"11","author":"Herrero-Mendez","year":"2009","journal-title":"Nat. Cell. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119836_bib61","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1248\/bpb.31.1177","article-title":"Effects of phosphorylation of immunomodulatory agent FTY720 (fingolimod) on antiproliferative activity against breast and colon cancer cells","volume":"31","author":"Nagaoka","year":"2008","journal-title":"Biol. Pharm. Bull."},{"issue":"9","key":"10.1016\/j.biopha.2026.119836_bib62","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.cellsig.2010.04.004","article-title":"Sphingosine and FTY720 directly bind pro-survival 14-3-3 proteins to regulate their function","volume":"22","author":"Woodcock","year":"2010","journal-title":"Cell. Signal."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T22:44:11Z","timestamp":1787179451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226008723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":62,"alternative-id":["S0753332226008723"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119836","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial bioenergetic remodeling underlies fingolimod-induced immunometabolic adaptation in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119836"}}